MTOR and cancer: In addition to the possible mechanism proposed in this study for CGEtOAc, combined with sorafenib-induced apoptosis in cancer cells, which involves increased ROS accumulation and inhibition of PI3K/Akt/mTOR expression, the apoptotic effects resulting from the combination treatment of compounds found in C. gigantea extracts and anticancer agents may be attributed to several mechanisms.